PMID: 11918625Mar 29, 2002Paper

Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients

Diabetic Medicine : a Journal of the British Diabetic Association
C W AhnK B Huh

Abstract

To investigate the association of clinical and immunological markers with diabetes classification in newly diagnosed young diabetic patients at disease onset. Eighty-two diabetic patients recruited within 1 year of onset (mean age 23.0 +/- 7.1, M:F = 46:36) were divided into three groups, namely: a low fasting C-peptide (FC) level at baseline group (the low FC group (n = 14, FC < 0.18 nmol/l)), an intermediate FC group (n = 29, 0.18 nmol/l < or = FC < 0.37 nmol/l), and a high FC group (n = 39, 0.37 nmol/l < or = FC). Patients were reclassified at follow-up (mean follow-up period 3.7 +/- 1.4 years) in the same manner as described above into low FC group (n = 31), intermediate FC group (n = 20), and high FC group (n = 31). The clinical characteristics and prevalence of GADA were compared. Patients in the high FC group at baseline had a higher body mass index (BMI), a higher frequency of a family history of diabetes, a higher meal-stimulated C-peptide increment, a lower frequency of ketonuria, a lower frequency of history of diabetic ketoacidosis, and a lower frequency of insulin therapy at diagnosis than those in the low and intermediate FC groups at baseline. Insulin secretory capacity, which was represented by fasting C-peptide...Continue Reading

References

Apr 1, 1992·Diabetes Research and Clinical Practice·K B HuhJ W Yoon
Oct 1, 1991·British Journal of Obstetrics and Gynaecology·K R PeelD J Thorogood
Apr 6, 1989·The New England Journal of Medicine·J KarjalainenM Knip
Jan 1, 1989·Diabetes Care·T KobayashiK Tsuji
Jul 1, 1981·Annals of Clinical Biochemistry·A M Bonser, P Garcia-Webb
Aug 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·H J ArnqvistL Wibell
Mar 1, 1996·Diabetes Research and Clinical Practice·H C LeeT Fugisawa

❮ Previous
Next ❯

Citations

Dec 8, 2010·Proteomics. Clinical Applications·Paul E OranRandall W Nelson
Sep 16, 2004·Pancreas·Ruy G MarquesJeffrey Rogers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.